Company Profiles

driven by the PitchBook Platform

acousia Therapeutics

Description

Provider and developer of therapeutics to prevent hearing loss. The company develops therapeutics to replace lost sensory hair cells, the key cells for hearing in the inner ear, by cellular regeneration originating from supporting cells.

2012

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

$2.64M

Latest Deal Amount

$2.64M

Total Amount Raised

3

Investors

Description

Provider and developer of therapeutics to prevent hearing loss. The company develops therapeutics to replace lost sensory hair cells, the key cells for hearing in the inner ear, by cellular regeneration originating from supporting cells.

Website:

www.acousia.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

Sindelfinger Straße 3 72070 TübingenGermany +49 (0)70 7129 8818 6
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore acousia Therapeutics's full profile, request a free trial.

    acousia Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    acousia Therapeutics Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    AxxamCorporationMinority000 0000000 0000
    Boehringer Ingelheim Venture FundCorporate Venture CapitalMinority000 0000000 0000
    KfW SME BankOtherMinority000 0000000 0000
    Axxam Corporation
    Boehringer Ingelheim Venture Fund Corporate Venture Capital
    KfW SME Bank Other

    acousia Therapeutics Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Michael Bös Ph.DChief Executive Officer
    Karl-Heinz WiesmullerCo-Founder
    Michael Bös Ph.D Chief Executive Officer
    Karl-Heinz Wiesmuller Co-Founder

    acousia Therapeutics Board Members (3)

    NameRepresentingRoleSinceContact
    Info
    Frank Kalkbrenner MDBoehringer IngelheimBoard Member000 0000
    Hubert Lowenheim MDacousia TherapeuticsCo-Founder & Board Member000 0000
    Stefan Lohmer Ph.DAxxamChief Executive Officer & Chairman000 0000
    Frank Kalkbrenner MD Board Member Boehringer Ingelheim
    Hubert Lowenheim MD Co-Founder & Board Member acousia Therapeutics
    Stefan Lohmer Ph.D Chief Executive Officer & Chairman Axxam
    Request full access to PitchBook